Skip to content

Clinical trials

Terminated Glioblastoma trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Status: Terminated Country / region: Canada Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20101
20111
20151
20201
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Exelixis1
Isarna Therapeutics GmbH1
Karyopharm Therapeutics Inc1
National Cancer Institute (NCI)1
Pediatric Brain Tumor Consortium1
Thallion Pharmaceuticals1
Tocagen Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma7
Brain Neoplasms5
Astrocytoma4
Glioma3
Oligodendroglioma2
Central Nervous System Neoplasms1
Ependymoma1
Gliosarcoma1
Medulloblastoma1
Neoplasms1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.